http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2326341-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c684df17c1e09127a3765f1138203f85 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-095 |
| filingDate | 2009-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9c5b9951db9da6b7d2dfef1ac86e546 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b34e65cbc17b8f30000842ddf7d82a0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_204677cf8392f73dd99e9251d2e8e116 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d02c9d29085f69173a7adc4b7d4a4363 |
| publicationDate | 2011-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-2326341-A2 |
| titleOfInvention | Peptide formulations and uses thereof |
| abstract | The present invention relates to the field of preventive and therapeutic medicine, in particular to peptide formulations. Provided is a p H-buffered aqueous formulation comprising oxytocin, vasopressin or an analogue thereof and at least one non-toxic source of divalent metal ions in a concentration of at least 2 m M, and the use of the formulation for the manufacture of a medicament for therapeutic and/or prophylactic treatments. Also provided is a method for treating or preventing haemorrhage in a subject in need thereof, comprising administering to said subject an effective dosage amount of an oxytocin formulation according to the invention. Further provided is a method for treating or preventing diabetes insipidus or vasodilatory shock in a subject in need thereof, comprising administering to said subject an effective dosage amount of a vasopressin formulation according to the invention. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9629894-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10806770-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11389473-B2 |
| priorityDate | 2008-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 71.